Bacteriology
Chimeric gene expression protects from lethal Escherichia coli infection
Published in Gene Therapy Weekly, May 18th, 2006
"Infections caused by gram-negative bacteria (GNB) often lead to high mortality in common clinical settings. The effect of traditional antibiotic therapy is hindered by drug-resistant bacteria and unneutralizable endotoxin," wrote Q.L. Kong and colleagues, Capital University of Medical Science.
They continued, "Few effective methods can protect high risk patients from bacterial infection. This study explored the protection of adeno-associated virus 2 (AAV2)-bacteriacidal permeability increasing protein 700...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-05-18)
More Articles from Gene Therapy Weekly
- Bloom Syndrome
Bloom syndrome gene expression silenced in human cells by gene targeting - Diabetes Gene Therapy
Type 1 diabetes genetic susceptibility is demonstrated by in vivo RNA interference - Epstein-Barr Virus
EBV antigens are re-targeted by T cells following TCR gene transfer - Gene Research
Mouse study reveals human gene therapy may pose substantial cancer risk - Neuroscience
Learning is impaired by NMDAR1 subunit knock-down in hippocampal neurons - Accreditation
CombiMatrix Molecular Diagnostics receives accreditation from CAP - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
